4/11/2024 | CVLM | Collegium calls all $26.35 million of 2.625% convertibles at par
|
2/21/2023 | CV | Collegium greenshoe exercised, ups convertibles to $241.5 million
|
2/8/2023 | CV | Market Commentary: Collegium convertible notes expand on debut; Oak Street adds; Royal Caribbean active
|
2/8/2023 | CV | Market Commentary: Morning Commentary: Collegium convertible notes jump on debut; Oak Street active
|
2/8/2023 | CV | New Issue: Collegium prices upsized $210 million six-year convertibles at 2.875%, up 30%
|
2/7/2023 | CV | Market Commentary: Collegium convertible offering eyed; Oak Street notes soar; Chegg notes up on swap
|
2/7/2023 | CV | Market Commentary: Morning Commentary: Collegium convertible offering eyed; Oak Street notes soar
|
2/6/2023 | CV | Market Commentary: Collegium convertibles on deck; Omeros surges; ON Semiconductor active post-earnings
|
2/6/2023 | CV | Collegium talks $175 million six-year convertible notes to yield 2.625%-3.125%, up 27.5%-32.5%
|
2/20/2020 | CV | Market Commentary: Pegasystems upsizes, expands on debut; Zillow mixed post-earnings; NextEra active
|
2/13/2020 | CV | Market Commentary: i3 Verticals exchangeables expand on debut; Barclays prices; Revance up; Tesla expands
|
2/13/2020 | CV | Collegium greenshoe ups convertibles to $143.75 million
|
2/12/2020 | CV | Market Commentary: i3 Verticals, Barclays synthetic eyed; Revance notes expand; Collegium adds to gains
|
2/11/2020 | CV | Market Commentary: i3 Verticals, Barclays synthetic on tap; Collegium notes expand; Revance, DISH eyed
|
2/11/2020 | CV | Market Commentary: Morning Commentary: Collegium Pharmaceuticals expands on debut; Revance, DISH eyed
|
2/10/2020 | CV | New Issue: Collegium Pharmaceutical prices $125 million 2.625% six-year convertibles, up 35%
|
2/10/2020 | CV | Market Commentary: Revance on tap; Collegium Pharmaceutical eyed; Nio in focus; Smart Global improves
|
2/10/2020 | BKPV | Collegium Pharmaceutical gets $200 million term loan from BioPharma
|
2/10/2020 | CV | Market Commentary: Morning Commentary: Collegium Pharmaceutical convertible notes eyed in early activity
|
2/10/2020 | CV | Collegium Pharmaceutical talks $125 million six-year convertibles at 2.625%-3.125%, up 30%-35%
|
1/8/2016 | PP | Collegium prices $55 million public offering of common stock at $20.00
|
5/12/2015 | PP | Collegium greenshoe exercised for $80.04 million IPO of common stock
|
5/7/2015 | PP | Collegium prices $69.6 million initial public sale of stock at $12.00
|
4/2/2015 | PP | Collegium may sell $86.25 million of stock in its initial public sale
|